These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39409187)

  • 1. The Expression of miR-211-5p in Sentinel Lymph Node Metastases of Malignant Melanoma Is a Potential Marker for Poor Prognosis.
    Moritz RKC; Ebelt N; Rattay T; Ehrenreich J; Sunderkötter C; Gerloff D
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.
    Koh SS; Wei JP; Li X; Huang RR; Doan NB; Scolyer RA; Cochran AJ; Binder SW
    Mod Pathol; 2012 Jun; 25(6):828-37. PubMed ID: 22411186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma.
    Lin Y; Liu J; Chen S; Wu Q; Shen F; Gan L
    Biochem Biophys Res Commun; 2024 Nov; 734():150338. PubMed ID: 39083978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma.
    Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G
    Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
    Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
    Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRASLND regulates melanoma cell progression by targeting the miR-218-5p/STAM2 axis.
    Ma A; Shi W; Chen L; Huang Z; Zhang Y; Tang Z; Jiang W; Xu M; Zhou J; Zhang W; Tang S
    J Transl Med; 2024 Jul; 22(1):684. PubMed ID: 39060946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
    Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
    Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
    Wang K; Zhang ZW
    Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
    Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
    Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
    Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
    J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-125b induces cellular senescence in malignant melanoma.
    Nyholm AM; Lerche CM; Manfé V; Biskup E; Johansen P; Morling N; Thomsen BM; Glud M; Gniadecki R
    BMC Dermatol; 2014 Apr; 14():8. PubMed ID: 24762088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.
    Babapoor S; Wu R; Kozubek J; Auidi D; Grant-Kels JM; Dadras SS
    Lab Invest; 2017 Jun; 97(6):636-648. PubMed ID: 28218741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
    Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
    J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.